Abstract
Introduction
More than 30 years ago, before patients with myasthenia gravis (MG) were treated with thymectomy and high-dose prednisolone (PSL), localized muscular atrophy was detectable in 5-10% of MG patients (1, 2) . In these cases, the facial muscles were relatively rarely involved (2) (3) (4) . Since then, the number of papers dealing with muscle atrophy in MG patients has decreased significantly. However, muscular atrophy, especially that involving the tongue and facial muscles, has been recently reported in MG patients with antimuscle-specific tyrosine kinase (MuSK) antibodies (5) (6) (7) (8) Fig. 1-A) , and lack of frontal wrinkles. There was no ptosis ( Fig. 1-B 
B i l a t e r a l f a c i a l we a k n e s s . A s h o ws t h e B e l l p h e n o me n o n . B s h o ws l a c k o f p t o s i s .

F i g u r e 2 . Ne e d l e e l e c t r o my o g r a p h y o f t h e r i g h t f r o n t a l i s mu s c l e . A a n d B s h o w t h e l o w o r n o r ma l a mp l i t u d e , p o l y p h a s i c MUP s . C s h o ws
a n i n c o mp l e t e i n t e r f e r e n c e p a t t e r n . (Fig. 2-A and B) , associated with an incomplete interference pattern (Fig. 2-C (1, 2) . In such cases, muscular atrophy usually involves the tongue, the scapulohumeral muscles, or the proximal limb muscles; facial muscular atrophy is relatively rare (2, 3, 9, 10 (3, 4) .
Discussion
This patient was diagnosed as having ACh-R antibodymediated MG because his serum ACh-R antibody titer was elevated and his blepharoptosis and orbicularis oris weakness improved with combination treatment that included oral corticosteroid and a cholinesterase inhibitor. One of the most characteristic findings in this patient was the presence of bi-
In MG patients with anti-MuSk antibodies, relatively specific atrophy of the tongue and facial muscles has been reported (5, 6) . In general, muscular atrophy of the tongue and facial muscles in MuSK-associated MG is more severe than that in ACh-R-associated MG (5 
